Please select the option that best describes you:

For a very high risk prostate cancer with relatively no elevation in PSA but no distant or nodal metastasis would you consider “neoadjuvant” ADT and chemotherapy prior to EBRT?   

In this case, Gleason 5+5 in all cores, clinical T4.

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Bon Secours Saint Mary's Hospital
Thank you for your detailed response I was thinki...
Sign in or Register to read more